The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

DaVita HealthCare Partners Inc

NYSE: DVA
Last

(U.S.) $79.61

Today's change0.00 0.00%
Updated June 29 4:01 PM EDT. Delayed by at least 15 minutes.
 

DaVita HealthCare Partners Inc

NYSE: DVA
Last

(U.S.) $79.61

Today's change0.00 0.00%
Updated June 29 4:01 PM EDT. Delayed by at least 15 minutes.

DaVita HealthCare Partners Inc closed at (U.S.)$79.61.

Shares have lost 3.07% over the last five days, but have gained 5.11% over the last year to date. This security has outperformed the S&P 500 by 4.20% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $79.61
  • High--
  • Low--
  • Bid / Ask(U.S.) $74.94 / (U.S.) $0.00
  • YTD % change+5.11%
  • Volume0
  • Average volume (10-day)1,301,472
  • Average volume (1-month)1,005,465
  • Average volume (3-month)950,491
  • 52-week range(U.S.) $70.41 to (U.S.) $85.17
  • Beta0.71
  • Trailing P/E40.48×
  • P/E 1 year forward21.12×
  • Forward PEG1.62×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $1.97
Updated June 29 4:01 PM EDT. Delayed by at least 15 minutes.
S&P TSX2.15%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2015Q4/2014Q3/2014Q2/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014
Revenue3,2883,3283,2523,172
Total other revenue--------
Total revenue3,2883,3283,2523,172
Gross profit925962925926
Total cost of revenue2,3632,3662,3272,247
Total operating expense3,3522,8762,8142,688
Selling / general / administrative344361327302
Research & development--------
Depreciation / amortization154153149146
Interest expense (income), net operating--------
Unusual expense (income)4950170
Other operating expenses, total--------
Operating income-64452438484
Interest income (expense), net non-operating-96-131-98-195
Gain (loss) on sale of assets--------
Other--------
Income before tax-162354336282
Income after tax-76250220181
Income tax, total-86104117101
Net income-111208184148
Total adjustments to net income----00
Net income before extra. items-111208184148
Minority interest-34-42-36-34
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-111208184148
Inc. avail. to common incl. extra. items-111208184148
Diluted net income-111208184148
Dilution adjustment--0----
Diluted weighted average shares213218217217
Diluted EPS excluding extraordinary itemsvalue per share-0.520.960.850.68
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.990.960.900.68